Evidence map›Paper›PMID 36759674›Full record

ArticleNature medicine2023

An EU task force to assess the burden of rare diseases.

Pavel Kolkhir, Diana Alecsandra Grad, Periklis Charalampous, Claudia Cruz Oliveira, Enkeleint A Mechili, Brigid Unim, David A Pearce, Marcus Maurer, Brecht Devleesschauwer, Juanita Haagsma

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pavel KolkhirInstitute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany. pavel.kolkhir@charite.de.ORCID http://orcid.org/0000-0001-5380-8132
Diana Alecsandra GradDepartment of Public Health, Babeş-Bolyai University, Cluj-Napoca, Romania.
Periklis CharalampousDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Claudia Cruz OliveiraDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Enkeleint A MechiliDepartment of Healthcare, Faculty of Health, University of Vlora, Vlora, Albania.
Brigid UnimDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
David A PearcePediatrics & Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA.
Marcus MaurerInstitute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-4121-481X
Brecht DevleesschauwerDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.ORCID http://orcid.org/0000-0002-2867-6892
Juanita HaagsmaDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Advisory CommitteesRare DiseasesEuropean UnionHumans

Identifiers

PMID36759674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.